Flavonoids as regulators of TIMPs expression in cancer: Consequences, opportunities, and challenges

Area of Science:

• Oncology
• Natural Product Chemistry
• Molecular Biology

Background:

• Cancer remains a leading cause of death globally, with invasion and metastasis driving mortality.
• Current cancer therapies face challenges of toxicity and chemoresistance, necessitating alternative treatments.
• Natural products, particularly flavonoids, exhibit promising antitumor activities.

Purpose of the Study:

• To review the regulation of tissue inhibitors of metalloproteinases (TIMPs) expression.
• To elucidate the role of flavonoids as therapeutic agents targeting TIMPs in cancer.
• To explore the mechanisms by which flavonoids exert chemopreventive and cytotoxic effects.

Main Methods:

• Literature review focusing on studies involving flavonoids, TIMPs, and cancer models (cell lines and in vivo).
• Analysis of signaling pathways regulated by flavonoids, including FAK, PI3K-Akt, STAT3, NFκB, and MAPK.
• Examination of flavonoid effects on extracellular matrix (ECM) turnover, cell migration, invasion, angiogenesis, and apoptosis.

Main Results:

• Flavonoids regulate TIMPs, which in turn control ECM turnover and inhibit matrix metalloproteinases (MMPs).
• Flavonoids demonstrate chemopreventive and cytotoxic effects against various cancers via multiple mechanisms.
• Flavonoids modulate critical cancer-related signaling pathways involved in metastasis.

Conclusions:

• Flavonoids exhibit significant antitumor potential by targeting TIMPs and influencing key oncogenic pathways.
• Flavonoids represent a promising natural product-based strategy for cancer therapy.
• Further research into flavonoids could lead to novel, less toxic cancer treatments.